Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/valsartan for heart failure
ChiCTR1900025506Phase 4Recruiting
- Sponsor
- China-Japan Union Hospital of Jilin University
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sacubitril + valsartan in heart failure (HF) (2 arms), sponsored by China-Japan Union Hospital of Jilin University. Primary endpoints: Electrocardiogram, left ventricular ejection fraction and 1 more. Started Aug 2018; status: recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ChiCTR1900025506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025506.